118 related articles for article (PubMed ID: 27842546)
21. Expression and purification of cysteine introduced recombinant saporin.
Günhan E; Swe M; Palazoglu M; Voss JC; Chalupa LM
Protein Expr Purif; 2008 Apr; 58(2):203-9. PubMed ID: 18164211
[TBL] [Abstract][Full Text] [Related]
22. Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
Liang OD; Chavakis T; Linder M; Bdeir K; Kuo A; Preissner KT
Biol Chem; 2003 Feb; 384(2):229-36. PubMed ID: 12675515
[TBL] [Abstract][Full Text] [Related]
23. Enhancing the production of Fc fusion protein in fed-batch fermentation of Pichia pastoris by design of experiments.
Lin H; Kim T; Xiong F; Yang X
Biotechnol Prog; 2007; 23(3):621-5. PubMed ID: 17461547
[TBL] [Abstract][Full Text] [Related]
24. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
25. [Biological function of fusion protein ATF-PAI2CD].
Wang X; Li P; Zhang YQ; Hou M; Sun XH; Tan L; Zhu YS
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):624-8. PubMed ID: 12883632
[TBL] [Abstract][Full Text] [Related]
26. Vitronectin binding to urokinase receptor in human breast cancer.
Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M
Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812
[TBL] [Abstract][Full Text] [Related]
27. Expression and anticancer activity analysis of recombinant human uPA1‑43-melittin.
Su M; Chang W; Cui M; Lin Y; Wu S; Xu T
Int J Oncol; 2015 Feb; 46(2):619-26. PubMed ID: 25394558
[TBL] [Abstract][Full Text] [Related]
28. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
29. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK.
Pham DD; Pham TH; Bui TH; Britikova EV; Britikov VV; Bocharov EV; Usanov SA; Phan VC; Le TBT
Mol Biol Rep; 2024 Jan; 51(1):130. PubMed ID: 38236367
[TBL] [Abstract][Full Text] [Related]
31. Optimization of human serum albumin production in methylotrophic yeast Pichia pastoris by repeated fed-batch fermentation.
Ohya T; Ohyama M; Kobayashi K
Biotechnol Bioeng; 2005 Jun; 90(7):876-87. PubMed ID: 15864809
[TBL] [Abstract][Full Text] [Related]
32. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
33. Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris.
Guo Y; Luan G; Shen G; Wu L; Jia H; Zhong Y; Li R; Li G; Shen Y; Sun J; Hu S; Xiao W
Appl Microbiol Biotechnol; 2013 Sep; 97(17):7669-77. PubMed ID: 23224405
[TBL] [Abstract][Full Text] [Related]
34. Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase.
Ruppert C; Mahavadi P; Wygrecka M; Weaver TE; Magdolen V; Idell S; Preissner KT; Seeger W; Günther A; Markart P
Thromb Haemost; 2008 Dec; 100(6):1185-92. PubMed ID: 19132247
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro.
Takei Y; Mizukami H; Saga Y; Kobayashi H; Suzuki M; Matsushita T; Ozawa K; Suzuki M
Int J Cancer; 2005 Jan; 113(1):54-8. PubMed ID: 15386422
[TBL] [Abstract][Full Text] [Related]
36. uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.
Guthaus E; Bürgle M; Schmiedeberg N; Hocke S; Eickler A; Kramer MD; Sweep CG; Magdolen V; Kessler H; Schmitt M
Biol Chem; 2002 Jan; 383(1):207-16. PubMed ID: 11930939
[TBL] [Abstract][Full Text] [Related]
37. A novel tumor targeting drug carrier for optical imaging and therapy.
Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
[TBL] [Abstract][Full Text] [Related]
38. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
[TBL] [Abstract][Full Text] [Related]
39. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of a rhIL-2-HSA fusion protein in Pichia pastoris using glucose as carbon source.
Guan B; Chen F; Lei J; Li Y; Duan Z; Zhu R; Chen Y; Li H; Jin J
Appl Biochem Biotechnol; 2013 Dec; 171(7):1792-804. PubMed ID: 23999737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]